| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.078 | 0.1 |